Home Featured Page 274

Featured

Latest

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Oakland Psychedelic Conference

MindMed’s LSD Neutralizer Study Begins

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s...

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

The Ultimate Guide to Pets and Psychedelics

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters...

Cambridge City Councilors Approve Psychedelics Decriminalization Measure

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in...

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian...

1...273274275...285 Page 274 of 285

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and Psychiatry’s, Wild Ride

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

Psychedelic Science 2025

Oakland Psychedelic Conference

MindMed’s LSD Neutralizer Study Begins

MindMed’s LSD Neutralizer Study Begins

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s...

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

The Ultimate Guide to Pets and Psychedelics

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters...

Cambridge City Councilors Approve Psychedelics Decriminalization Measure

Tryp Therapeutics Launches Clinical Trials to Investigate Psilocybin for Over-Eating Disorders

Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in...

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian...

EDITOR PICKS

Hope, Hype, and Humility: Dr. Charles Raison Reflects on Psychedelics’, and...

High Hopes in the Mile High City: Inside Colorado’s First Licensed...

LP Giobbi – Dead House, Psychedelic Creativity, and Fem House Empowerment

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY